Artoss Launching NanoBone QD Bone Graft
Artoss introduced NanoBone® QD bone graft, comprising NanoBone SBX putty in an application designed for quick delivery....
Oct 23, 2017,
Artoss Launching NanoBone QD Bone Graft
FzioMed Receives FDA Approval Oxiplex Study
FzioMed received FDA approval to conduct a small confirmatory study of Oxiplex® synthetic viscoelastic gel, examining its use following lumbar surgery....
Oct 23, 2017,
Smith & Nephew to Acquire Rotation Medical
Smith & Nephew entered into a definitive agreement to acquire Rotation Medical for US $125MM in initial cash. The transaction is expected to...
Oct 23, 2017,
Exactech to Become Privately-Held Company
Via terms of a definitive agreement with TPG Capital, Exactech is slated to become a privately-held company in 1Q18....
Oct 23, 2017,
DePuy Synthes 3Q17 Orthopaedic Revenue +0.5% YoY
ORTHOWORLD estimates DePuy Synthes’ 3Q17 orthopaedic revenue at US $2,120.6MM, +0.5% vs. 3Q16, with 9 months 2017 revenue of $6,545.8MM,...
Oct 23, 2017,
RTI Surgical Introduces TETRAfuse 3D-Printed Interbody Polymer Material
RTI Surgical introduced TETRAfuse®, reportedly the first 3D-printed polymer implant material to demonstrate trabecular bone ingrowth plus radiolucency and bone-like mechanical properties....
Oct 23, 2017,
Spineology Initiates Postmarket Study of Duo Lumbar Interbody Fusion System
Spineology launched a postmarket study to assess patient outcomes with the Duo™ Lumbar Interbody Fusion system....
Oct 20, 2017,
Bruce Stroever on 30 Years of Leadership at MTF
In his nearly 30 years with MTF, Bruce Stroever has watched the entity grow to more than 1,100 employees and...
Oct 19, 2017,
NuVasive Launches 3D-Printed Modulus XLIF Titanium Implants
NuVasive launched Modulus® XLIF®, 3D-printed titanium implants for use in lateral lumbar interbody fusion....
Oct 19, 2017,
Implanet Gains CE Mark Approval for JAZZ Passer
Implanet received approval under the CE Mark to market the JAZZ® Passer, used in posterior fixation procedures....
Oct 19, 2017,
Loading new posts...
No more posts
